Sex-dependent decrease of sphingomyelinase activity during alcohol withdrawal treatment

Cellular Physiology and Biochemistry

Volumn 34, Issue 1, 2014, Pages 71-81

  Mühle, Christiane ^a   Amova, Violina ^a   Biermann, Teresa ^a   Bayerlein, Kristina ^a,d   Richter Schmidinger, Tanja ^a   Kraus, Thomas ^b   Reichel, Martin ^a   Gulbins, Erich ^c   Kornhuber, Johannes ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Psychosom Medicine and Rehabilitation from Addiction   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d Regional Hospital of Middle Frankonia Department of Psychiatry Addiction Psychotherapy and Psychosomatic Medicine   (Germany)

Author keywords

Acid sphingomyelinase; Alcohol dependence; Craving; Depression; Gender; Psychometrics; Withdrawal

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; SPHINGOMYELIN PHOSPHODIESTERASE;

ADULT; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; DEPRESSION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DRINKING SCALE; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; SEX DIFFERENCE; WITHDRAWAL SYNDROME SCALE; ALCOHOLISM; BLOOD; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; TIME; WITHDRAWAL SYNDROME; ALCOHOL CONSUMPTION; CHRONIC PATIENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRINKING BEHAVIOR; GENDER; GLOBAL ASSESSMENT OF FUNCTIONING; TIME SERIES ANALYSIS;

ADULT; ALCOHOLISM; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; SEX FACTORS; SPHINGOMYELIN PHOSPHODIESTERASE; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 84904001337     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000362985     Document Type: Article

References (46)

1. World Health Organization: Global status report on alcohol and health 2011.
2. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J: Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009;373:2223-2233.
3. Baraona E, Lieber CS: Effects of ethanol on lipid metabolism. J Lipid Res 1979;20:289-315. (Pubitemid 9137739)
4. Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S: Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 2006;1758:2016-2026. (Pubitemid 44879368)
5. Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, Olah Z, Olivera A, Pirianov G, Thomas DM, Tu Z, Van Brocklyn JR, Wang F: Sphingosine-1- phosphate in cell growth and cell death. Ann N Y Acad Sci 1998;845:11-18. (Pubitemid 28365296)
6. Hannun YA, Obeid LM: The ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind. J Biol Chem 2002;277:25847-25850. (Pubitemid 34967060)
7. Weinreb NJ, Brady RO, Tappel AL: The lysosomal localization of sphingolipid hydrolases. Biochim Biophys Acta 1968;159:141-146.
8. Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I: The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 1998;273:18250- 18259. (Pubitemid 28334747)
9. Liu JJ, Wang JY, Hertervig E, Cheng Y, Nilsson A, Duan RD: Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells. Alcohol Alcohol 2000;35:569-573.
10. Pascual M, Valles SL, Renau-Piqueras J, Guerri C: Ceramide pathways modulate ethanol-induced cell death in astrocytes. J Neurochem 2003;87:1535-1545. (Pubitemid 38020587)
11. Saito M, Cooper TB, Vadasz C: Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons. Alcohol Clin Exp Res 2005;29:1374-1383. (Pubitemid 41243361)
12. Deaciuc IV, Nikolova-Karakashian M, Fortunato F, Lee EY, Hill DB, McClain CJ: Apoptosis and dysregulated ceramide metabolism in a murine model of alcohol-enhanced lipopolysaccharide hepatotoxicity. Alcohol Clin Exp Res 2000;24:1557-1565.
13. Liangpunsakul S, Rahmini Y, Ross RA, Zhao Z, Xu Y, Crabb DW: Imipramine blocks ethanol-induced asmase activation, ceramide generation, and pp2a activation, and ameliorates hepatic steatosis in ethanol-fed mice. Am J Physiol Gastrointest Liver Physiol 2012;302:G515-523.
14. Fernandez A, Matias N, Fucho R, Ribas V, Von Montfort C, Nuno N, Baulies A, Martinez L, Tarrats N, Mari M, Colell A, Morales A, Dubuquoy L, Mathurin P, Bataller R, Caballeria J, Elena M, Balsinde J, Kaplowitz N, Garcia-Ruiz C, Fernandez-Checa JC: ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading. J Hepatol 2013;59:805-813.
15. Reichel M, Greiner E, Richter-Schmidinger T, Yedibela Ö, Tripal P, Jacobi A, Bleich S, Gulbins E, Kornhuber J: Increased acid sphingomyelinase activity in peripheral blood cells of acutely intoxicated patients with alcohol dependence. Alcohol Clin Exp Res 2010;34:46-50.
16. Reichel M, Beck J, Mühle C, Rotter A, Bleich S, Gulbins E, Kornhuber J: Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients. Alcohol Clin Exp Res 2011;35:1852-1859.
17. Bleich S, Carl M, Bayerlein K, Reulbach U, Biermann T, Hillemacher T, Bönsch D, Kornhuber J: Evidence of increased homocysteine levels in alcoholism: The franconian alcoholism research studies (FARS). Alcohol Clin Exp Res 2005;29:334-336. (Pubitemid 40446124)
18. Wetterling T, Kanitz RD, Besters B, Fischer D, Zerfass B, John U, Spranger H, Driessen M: A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS scale). Alcohol Alcohol 1997;32:753-760. (Pubitemid 28006015)
19. Anton RF, Moak DH, Latham PK: The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 1996;53:225-231. (Pubitemid 26085204)
20. Mann K, Ackermann K: Die OCDS-G: Psychometrische Kennwerte der deutschen Version der Obsessive Compulsive Drinking Scale. Sucht 2000;46:90-100. (Pubitemid 30387287)
21. Wetterling T, Veltrup C, Junghanns K: How to assess craving for alcohol. Eur Addict Res 1997;3:110-115. (Pubitemid 27296629)
22. Fagerström KO: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978;3:235-241. (Pubitemid 9098397)
23. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO: The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. Br J Addict 1991;86:1119-1127.
24. Bleich S, Havemann-Reinecke U, Kornhuber J: Der Fagerström-Test für Nikotinabhängigkeit (FTNA). Beltz Test GmbH 2002; Göttingen.
25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
26. Hautzinger M, Bailer M, H. W, Keller F: Beck-Depressions-Inventar (BDI). Testhandbuch Bern, Göttingen, Toronto, Seattle: Verlag Hans Huber 1994.
27. Hall RC: Global assessment of functioning. A modified scale. Psychosomatics 1995;36:267-275.
28. Saß H, Wittchen HU, Zaudig M, Houben I: Diagnostische Kriterien des diagnostischen und statistischen Manuals psychischer Störungen. DSM IV. Göttingen: Hogrefe 2003:47-49.
29. Diener E, Emmons RA, Larsen RJ, Griffin S: The satisfaction with life scale. J Pers Assess 1985;49:71-75. (Pubitemid 15080385)
30. Schumacher J, Klaiberg A, Brähler E: Diagnostische Verfahren zu Lebensqualität und Wohlbefinden. Göttingen: Hogrefe 2003:305-309.
31. Mühle C, Huttner HB, Walter S, Reichel M, Canneva F, Lewczuk P, Gulbins E, Kornhuber J: Characterization of acid sphingomyelinase activity in human cerebrospinal fluid. PLOS ONE 2013;8:e62912.
32. Wilsnack RW, Vogeltanz ND, Wilsnack SC, Harris TR, Ahlstrom S, Bondy S, Csemy L, Ferrence R, Ferris J, Fleming J, Graham K, Greenfield T, Guyon L, Haavio-Mannila E, Kellner F, Knibbe R, Kubicka L, Loukomskaia M, Mustonen H, Nadeau L, Narusk A, Neve R, Rahav G, Spak F, Teichman M, Trocki K, Webster I, Weiss S: Gender differences in alcohol consumption and adverse drinking consequences: Cross-cultural patterns. Addiction 2000;95:251-265. (Pubitemid 30111246)
33. Forquer MR, Hashimoto JG, Roberts ML, Wiren KM: Elevated testosterone in females reveals a robust sex difference in altered androgen levels during chronic alcohol withdrawal. Alcohol 2011;45:161-171.
34. Lee JT, Peng GS, Chen SY, Hsu CH, Lin CC, Cheng CA, Hsu YD, Lin JC: Homocysteine induces cerebral endothelial cell death by activating the acid sphingomyelinase ceramide pathway. Prog Neuropsychopharmacol Biol Psychiatry 2013;45:21-27.
35. Bleich S, Degner D, Wiltfang J, Maler JM, Niedmann P, Cohrs S, Mangholz A, Porzig J, Sprung R, Rüther E, Kornhuber J: Elevated homocysteine levels in alcohol withdrawal. Alcohol Alcohol 2000;35:351-354. (Pubitemid 30604024)
36. Marathe S, Schissel SL, Yellin MJ, Beatini N, Mintzer R, Williams KJ, Tabas I: Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem 1998;273:4081-4088. (Pubitemid 28103275)
37. Rhein C, Tripal P, Seebahn A, Konrad A, Kramer M, Nagel C, Kemper J, Bode J, Mühle C, Gulbins E, Reichel M, Becker CM, Kornhuber J: Functional implications of novel human acid sphingomyelinase splice variants. PLOS ONE 2012;7:e35467.
38. Doehner W, Bunck AC, Rauchhaus M, von Haehling S, Brunkhorst FM, Cicoira M, Tschope C, Ponikowski P, Claus RA, Anker SD: Secretory sphingomyelinase is upregulated in chronic heart failure: A second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur Heart J 2007;28:821-828. (Pubitemid 47343591)
39. Majumdar I, Mastrandrea LD: Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Endocrine 2012;41:442-449.
40. Kornhuber J, Medlin A, Bleich S, Jendrossek V, Henkel AW, Wiltfang J, Gulbins E: High activity of acid sphingomyelinase in major depression. J Neural Transm 2005;112:1583-1590. (Pubitemid 41504272)
41. Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, Mühle C, Terfloth L, Groemer TW, Spitzer GM, Liedl KR, Gulbins E, Tripal P: Identification of novel functional inhibitors of acid sphingomyelinase. PLOS ONE 2011;6:e23852.
42. Kornhuber J, Tripal P, Reichel M, Mühle C, Rhein C, Muehlbacher M, Groemer TW, Gulbins E: Functional inhibitors of acid sphingomyelinase (FIASMAS): A novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 2010;26:9-20.
43. Gulbins E, Palmada M, Reichel M, Lüth A, Böhmer C, Amato D, Müller CP, Tischbirek CH, Groemer TW, Tabatabai G, Becker KA, Tripal P, Staedtler S, Ackermann TF, van Brederode J, Alzheimer C, Weller M, Lang UE, Kleuser B, Grassme H, Kornhuber J: Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med 2013;19:934-938.
44. Mielke MM, Bandaru VV, Haughey NJ, Rabins PV, Lyketsos CG, Carlson MC: Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging 2010;31:17-24.
45. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B, Group WIS: CDT GGT, and AST as markers of alcohol use: The WHO/ISBRA collaborative project. Alcohol Clin Exp Res 2002;26:332-339. (Pubitemid 34225837)
46. Reichel M, Richter-Schmidinger T, Mühle C, Rhein C, Alexopoulos P, Kornhuber J: The common acid sphingomyelinase polymorphism G508R is associated with self-reported allergy. Cell Physiol Biochem 2014;34:82-91.